ABSTRACT
There is an ongoing debate whether the intake of soy-derived isoflavones (sISO) mediates beneficial or adverse effects with regard to breast cancer risk. Therefore, we investigated whether nutritional exposure to a sISO-enriched diet from conception until adulthood impacts on 17ß-estradiol (E2)-induced carcinogenesis in the rat mammary gland (MG). August-Copenhagen-Irish (ACI) rats were exposed to dietary sISO from conception until postnatal day 285. Silastic tubes containing E2 were used to induce MG tumorigenesis. Body weight, food intake, and tumor growth were recorded weekly. At necropsy, the number, position, size, and weight of each tumor were determined. Plasma samples underwent sISO analysis, and the morphology of MG was analyzed. Tumor incidence and multiplicity were reduced by 20 and 56 %, respectively, in the sISO-exposed rats compared to the control rats. Time-to-tumor onset was shortened from 25 to 20 weeks, and larger tumors developed in the sISO-exposed rats. The histological phenotype of the MG tumors was independent of the sISO diet received, and it included both comedo and cribriform phenotypes. Morphological analyses of the whole-mounted MGs also showed no diet-dependent differences. Lifelong exposure to sISO reduced the overall incidence of MG carcinomas in ACI rats, although the time-to-tumor was significantly shortened.
Subject(s)
Estradiol/toxicity , Glycine max/chemistry , Isoflavones/toxicity , Mammary Neoplasms, Experimental/chemically induced , Tumor Burden/drug effects , Animals , Diet , Female , Isoflavones/isolation & purification , Isoflavones/pharmacology , Mammary Neoplasms, Experimental/metabolism , Mammary Neoplasms, Experimental/pathology , Rats, Inbred ACI , Time FactorsABSTRACT
BACKGROUND: Unpacking molecular perturbations associated with features of schizophrenia is a critical step toward understanding phenotypic heterogeneity in this disorder. Recent epigenome-wide association studies have uncovered pervasive dysregulation of DNA methylation in schizophrenia; however, clinical features of the disorder that account for a large proportion of phenotypic variability are relatively underexplored. METHODS: We comprehensively analyzed patterns of DNA methylation in a cohort of 381 individuals with schizophrenia from the deeply phenotyped Australian Schizophrenia Research Bank. Epigenetic changes were investigated in association with cognitive status, age of onset, treatment resistance, Global Assessment of Functioning scores, and common variant polygenic risk scores for schizophrenia. We subsequently explored alterations within genes previously associated with psychiatric illness, phenome-wide epigenetic covariance, and epigenetic scores. RESULTS: Epigenome-wide association studies of the 5 primary traits identified 662 suggestively significant (p < 6.72 × 10-5) differentially methylated probes, with a further 432 revealed after controlling for schizophrenia polygenic risk on the remaining 4 traits. Interestingly, we uncovered many probes within genes associated with a variety of psychiatric conditions as well as significant epigenetic covariance with phenotypes and exposures including acute myocardial infarction, C-reactive protein, and lung cancer. Epigenetic scores for treatment-resistant schizophrenia strikingly exhibited association with clozapine administration, while epigenetic proxies of plasma protein expression, such as CCL17, MMP10, and PRG2, were associated with several features of schizophrenia. CONCLUSIONS: Our findings collectively provide novel evidence suggesting that several features of schizophrenia are associated with alteration of DNA methylation, which may contribute to interindividual phenotypic variation in affected individuals.
Subject(s)
DNA Methylation , Schizophrenia , Humans , Schizophrenia/genetics , Australia , Epigenesis, Genetic , Epigenome , Genome-Wide Association StudyABSTRACT
Nanoplastics, as emerging pollutants, have drawn increasing concerns for their potential threats to agriculture and food security. ZnO nanoparticles (nano-ZnO), serving as ideal nano-fertilizer dispersion in sustainable agriculture, might be a promising application for nanoplastic stress management. To determine the role of nano-ZnO in regulating crop response towards nanoplastic pollutions, corn (Zea mays L.) seedlings after leaf treatment by nano-ZnO were foliar exposed to polystyrene nanoplastics (PSNPs). The presence of nano-ZnO significantly reduced the accumulation of PSNPs in corn leaf, stem and root tissues by 40.7 %-71.4 %. Physiologically, nano-ZnO prominently decreased the extent of PSNP-induced reduction in chlorophyll content and photosynthetic rates, thereby greatly weakening the toxic effects of PSNPs on corn plant growth. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) analyses demonstrated that responsive differentially expressed genes involved in photosynthesis, glutathione metabolism and phytohormone signal transduction pathways explained the enhanced tolerance of corn plants to PSNPs under the addition of nano-ZnO. Among the key genes of photosynthesis, nano-ZnO ensured the regular expression of chlorophyll synthesis genes (CHLH, CHLD, CHLM, DVR, GTR and POR), photosystem II gene (PetH), and carbon fixation enzyme genes (pepc, rbcL and rbcS) inhibited by PSNP exposure. These findings enlarge our understanding of the mechanism by which nano-ZnO attenuates the negative effects of nanoplastics on crops, which is of great significance for improving the sustainable utilization of nano-fertilizers in agriculture.
Subject(s)
Microplastics , Zea mays , Microplastics/metabolism , Transcriptome , Chlorophyll/metabolism , Photosynthesis , FertilizersABSTRACT
In breast cancer, dysregulated TP53 expression signatures are a better predictor of chemotherapy response and survival outcomes than TP53 mutations. Our previous studies have shown that high levels of Δ40p53 are associated with worse disease-free survival and disruption of p53-induced DNA damage response in breast cancers. Here, we further investigated the in vitro and in vivo implications of Δ40p53 expression in breast cancer. We have shown that genes associated with cell differentiation are downregulated while those associated with stem cell regulation are upregulated in invasive ductal carcinomas expressing high levels of Δ40p53. In contrast to p53, endogenous ∆40p53 co-localised with the stem cell markers Sox2, Oct4, and Nanog in MCF-7 and ZR75-1 cell lines. ∆40p53 and Sox2 co-localisation was also detected in breast cancer specimens. Further, in cells expressing a high ∆40p53:p53 ratio, increased expression of stem cell markers, greater mammosphere and colony formation capacities, and downregulation of miR-145 and miR-200 (p53-target microRNAs that repress stemness) were observed compared to the control subline. In vivo, a high ∆40p53:p53 ratio led to increased tumour growth, Ki67 and Sox2 expression, and blood microvessel areas in the vehicle-treated mice. High expression of ∆40p53 also reduced tumour sensitivity to doxorubicin compared to control tumours. Enhanced therapeutic efficacy of doxorubicin was observed when transiently targeting Δ40p53 or when treating cells with OTSSP167 with concomitant chemotherapy. Taken together, high Δ40p53 levels induce tumour growth and may promote chemoresistance by inducing a stemness phenotype in breast cancer; thus, targeting Δ40p53 in tumours that have a high Δ40p53:p53 ratio could enhance the efficacy of standard-of-care therapies such as doxorubicin.
Subject(s)
MicroRNAs , Neoplasms , Animals , Mice , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Cell Line, Tumor , Doxorubicin/pharmacology , Doxorubicin/therapeutic use , MicroRNAs/genetics , MicroRNAs/metabolism , Protein Isoforms/metabolismABSTRACT
Cadmium (Cd) is one of the most toxic and widely distributed pollutants in mining sites of Northeast China, and how Cd contamination may affect the fungal characteristics of the zonal Haplic Cambisols is still unknown. The study aims to investigate the richness and diversity of fungal community in Haplic Cambisols in response to Cd treatments and to infer Cd-resistant fungal genera. Haplic Cambisol was treated with different concentrations of CdCl2·2.5H2O solution (0 mg kg-1, 1 mg kg-1, 5 mg kg-1, 25 mg kg-1, and 50 mg kg-1, expressed as CK, T1, T2, T3, and T4, respectively), and fungal community was analyzed by high-throughput sequencing technology at 30 days, 60 days, or 80 days after Cd treatment (expressed as d30, d60, and d80, respectively). The results showed that Cd treatment usually increased the richness and diversity indices, the variation of diversity index under different Cd concentrations was not obvious, and different Cd incubation times had an inhibitory effect on fungal richness, but the diversity first increased and then decreased. Besides, Ascomycota and Mortierellomycota having the highest abundance in Haplic Cambisols showed the most pronounced changes under Cd treatment. Accordingly, Cd-resistant fungi were also found, such as Aspergillus, Fusarium, Penicillium, and Trichoderma, especially Aspergillus, which had relatively high abundance. The results obtained in this study had potentially significant findings for soil biodiversity and Cd bioremediation.
Subject(s)
Cadmium , Mycobiome , Cadmium/toxicity , Soil Microbiology , Fungi , SoilABSTRACT
Breast cancer is the most diagnosed malignancy in women, with over half a million women dying from this disease each year. In our previous studies, ∆40p53, an N-terminally truncated p53 isoform, was found to be upregulated in breast cancers, and a high ∆40p53 : p53α ratio was linked with worse disease-free survival. Although p53α inhibits cancer migration and invasion, little is known about the role of ∆40p53 in regulating these metastasis-related processes and its role in contributing to worse prognosis. The aim of this study was to assess the role of ∆40p53 in breast cancer migration and invasion. A relationship between Δ40p53 and gene expression profiles was identified in oestrogen-receptor-positive breast cancer specimens. To further evaluate the role of Δ40p53 in oestrogen-receptor-positive breast cancer, MCF-7 and ZR75-1 cell lines were transduced to knockdown p53α or Δ40p53 and overexpress Δ40p53. Proliferation, migration and invasion were assessed in the transduced sublines, and gene expression was assessed through RNA-sequencing and validated by reverse-transcription quantitative PCR. Knockdown of both p53α and ∆40p53 resulted in increased proliferation, whereas overexpression of ∆40p53 reduced proliferation rates. p53α knockdown was also associated with increased cell mobility. ∆40p53 overexpression reduced both migratory and invasive properties of the transduced cells. Phenotypic findings are supported by gene expression data, including differential expression of LRG1, HYOU1, UBE2QL1, SERPINA5 and PCDH7. Taken together, these results suggest that, at the basal level, ∆40p53 works similarly to p53α in suppressing cellular mobility and proliferation, although the role of Δ40p53 may be cell context-specific.
Subject(s)
Breast Neoplasms/pathology , Neoplasm Invasiveness , Neoplasm Metastasis , Protein Isoforms/physiology , Tumor Suppressor Protein p53/physiology , Breast Neoplasms/metabolism , Cell Line, Tumor , Cell Proliferation , Female , Gene Expression Profiling , Gene Knockdown Techniques , Humans , Protein Isoforms/genetics , Reverse Transcriptase Polymerase Chain Reaction , Tumor Suppressor Protein p53/geneticsABSTRACT
Our previous studies have shown that p53 isoform expression is altered in breast cancer and related to prognosis. In particular, a high ∆40p53:p53α ratio is associated with worse disease-free survival. In this manuscript, the influence of altered Δ40p53 and p53α levels on the response to standard of care DNA-damaging agents used in breast cancer treatment was investigated in vitro. Our results revealed that a high Δ40p53:p53α ratio causes cells to respond differently to doxorubicin and cisplatin treatments. Δ40p53 overexpression significantly impairs the cells' sensitivity to doxorubicin through reducing apoptosis and DNA damage, whereas Δ40p53 knockdown has the opposite effect. Further, a high Δ40p53:p53α ratio inhibited the differential expression of several genes following doxorubicin and promoted DNA repair, impairing the cells' canonical response. Overall, our results suggest that the response of breast cancer cells to standard of care DNA-damaging therapies is dependent on the expression of p53 isoforms, which may contribute to outcomes in breast cancer.
Subject(s)
Breast Neoplasms , Tumor Suppressor Protein p53 , Humans , Female , Tumor Suppressor Protein p53/genetics , Tumor Suppressor Protein p53/metabolism , Breast Neoplasms/genetics , Protein Isoforms/genetics , Protein Isoforms/metabolism , DNA Damage/genetics , Doxorubicin/pharmacologyABSTRACT
The tumour suppressor p53 is essential for maintaining DNA integrity, and plays a major role in cellular senescence and aging. Understanding the mechanisms that contribute to p53 dysfunction can uncover novel possibilities for improving cancer therapies and diagnosis, as well as cognitive decline associated with aging. In recent years, the complexity of p53 signalling has become increasingly apparent owing to the discovery of the p53 isoforms. These isoforms play important roles in regulating cell growth and turnover in response to different stressors, depending on the cellular context. In this review, we focus on Δ40p53, an N-terminally truncated p53 isoform. Δ40p53 can alter p53 target gene expression in both a positive and negative manner, modulating the biological outcome of p53 activation; it also functions independently of p53. Therefore, proper control of the Δ40p53: p53 ratio is essential for normal cell growth, aging, and responses to cancer therapy. Defining the contexts and the mechanisms by which Δ40p53 behaves as a "good cop or bad cop" is critical if we are to target this isoform therapeutically.
ABSTRACT
Cancer cell mobility is crucial for the initiation of metastasis. Therefore, investigation of the cell movement and invasive capacity is of great significance. Migration assays provide basic insight of cell movement at a 2D level, whereas invasion assays are more physiologically relevant, mimicking in vivo cancer cell dislodgment from the original site and invading through the extracellular matrix. The current protocol provides a single workflow for migration and invasion assays. Together with the integrated automated microscopic camera for real-time HD images and built-in analysis module, it gives researchers a time-efficient, simple and reproducible experimental option. This protocol also includes substitutions for the consumables and alternative analysis methods for users to choose from.